Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4535 results

Sort By:

Filter Lenses for the Prevention of Migraine Attacks

Study ID: NCT06161129
Start Date: 2026-03-01
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Lenses

Sponsor

Rune Skovgaard Rasmussen

Source: clinicaltrials.gov

Share:
Add to list

Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery

Study ID: NCT06903429
Start Date: 2025-05-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

330

Intervention / Treatment

Targeting of axillary lymph nodes using LuminoMark

Targeting of axillary lymph nodes using conventional method

Sponsor

Kungpuka National University Chilgok Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis

Study ID: NCT06582329
Start Date: 2025-04
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

16

Intervention / Treatment

Alfa1 Antitrypsin

Sponsor

Medical University Innsbruck

Source: clinicaltrials.gov

Share:
Add to list

Qnnections: Refinement and Pilot Trial of a Suicide Prevention Intervention to Increase Social Connection

Study ID: NCT06803329
Start Date: 2025-10-01
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment

Qnnections

Enhanced Usual Care

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions

Study ID: NCT06823362
Start Date: 2025-04-10
End Date: 2025-09-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

40

Intervention / Treatment

Pentoxifylline

Pentoxifylline

Sponsor

Medical Care and Research Center

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Study ID: NCT06719362
Start Date: 2025-10
End Date: 2030-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

110

Intervention / Treatment

M3T01

Pembrolizumab

Chemoradiation

FOLFOX regimen

Sponsor

Providence Health & Services

Source: clinicaltrials.gov

Share:
Add to list

Development of Patient-Reported Outcome Measures Assessing Tumor-Related Disfigurement and Appearance Concerns in Neurofibromatosis Type 1

Study ID: NCT06880991
Start Date: 2025-04-03
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Arm 1

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

10-year Follow-up After Aortic Valve Replacement Surgery

Study ID: NCT06255691
Start Date: 2025-04-10
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

282

Intervention / Treatment
Sponsor

Oslo University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 Mg in Patients with Advanced Prostate Cancer

Study ID: NCT06795191
Start Date: 2025-06-01
End Date: 2028-01-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

148

Intervention / Treatment

Triptorelin Mesylate

Sponsor

Foresee Pharmaceuticals Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Improving Health and Wellness for People with Serious Mental Illness in Puerto Rico

Study ID: NCT06859060
Start Date: 2025-08
End Date: 2029-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

BRIDGES Healthcare Manager Intervention

Enhanced Treatment as Usual (ETAU)

Sponsor

Ponce Medical School Foundation, Inc.

Source: clinicaltrials.gov

Share:
Add to list